NCT02672592View on ClinicalTrials.gov

Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
HypogonadismMetabolic Syndrome XObesity
Interventions
DRUG

Anakinra

Anakinra 100mg s.c. bid

DRUG

Sodium Chloride 0.9%

Sodium Chloride 0.9% s.c. bid

Trial Locations (2)

4031

University Hospital Basel, Basel

5001

University Department of Medicine, Kantonsspital Aarau, Aarau

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02672592 - Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome | Biotech Hunter | Biotech Hunter